Literature DB >> 1478845

Serum ferritin in newly diagnosed and poorly controlled diabetes mellitus.

S F Dinneen1, M S O'Mahony, T O'Brien, C C Cronin, D M Murray, D J O'Sullivan.   

Abstract

Serum ferritin was measured in 50 patients at diagnosis of diabetes mellitus (DM) and in 20 patients with established DM and poor metabolic control. Twenty-two patients had hyperferritinemia at diagnosis. Four patients had a recognised cause for their hyperferritinemia. In the remaining 18 patients ferritin levels decreased from a mean of 506 +/- 3.6 (SE) ug/l at diagnosis to 254 +/- 29.2 ug/l seven months later (p < 0.001). Metabolic control improved significantly over the same time. All 20 patients with established DM and poor metabolic control had normal ferritin levels. When compared with the newly diagnosed hyperferritinemic patients no difference was found in levels of glycosylated haemoglobin, but ferritin values differed significantly between the two groups (p < 0.001). These results indicate that transient hyperferritinemia is a feature of newly diagnosed DM but not of established DM with poor control. If used to screen diabetic patients for haemochromatosis, serum ferritin should be measured in established DM rather than at diagnosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1478845     DOI: 10.1007/bf02983771

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  10 in total

1.  Screening for hemochromatosis.

Authors:  M L Bassett; J W Halliday; S Bryant; O Dent; L W Powell
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

2.  Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release.

Authors:  A M Konijn; C Hershko
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

Review 3.  Serum ferritin.

Authors:  M Worwood
Journal:  Clin Sci (Lond)       Date:  1986-03       Impact factor: 6.124

Review 4.  Ferritin in human tissues and serum.

Authors:  M Worwood
Journal:  Clin Haematol       Date:  1982-06

5.  Increased serum ferritin levels of hyperthyroidism.

Authors:  C I Macaron; Z G Macaron
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391

6.  Serum ferritin in patients with iron overload and with acute and chronic liver diseases.

Authors:  J Prieto; M Barry; S Sherlock
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

7.  Usefulness of biochemical screening of diabetic patients for hemochromatosis.

Authors:  T O'Brien; B Barrett; D M Murray; S Dinneen; D J O'Sullivan
Journal:  Diabetes Care       Date:  1990-05       Impact factor: 19.112

8.  Ferritin in serum: diagnosis of iron deficiency and iron overload in infants and children.

Authors:  M A Siimes; J E Addiego; P R Dallman
Journal:  Blood       Date:  1974-04       Impact factor: 22.113

9.  Plasma ferritin in an elderly population living in the community.

Authors:  J Woo; Y T Mak; L K Law; R Swaminathan
Journal:  J Med       Date:  1989

10.  Deferoxamine therapy in high-ferritin diabetes.

Authors:  P Cutler
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

  10 in total
  3 in total

1.  Age-dependent and gender-specific changes in mouse tissue iron by strain.

Authors:  Paul Hahn; Ying Song; Gui-shuang Ying; Xining He; John Beard; Joshua L Dunaief
Journal:  Exp Gerontol       Date:  2009-06-27       Impact factor: 4.032

2.  Biomarkers of body iron stores and risk of developing type 2 diabetes.

Authors:  S N Rajpathak; J Wylie-Rosett; M J Gunter; A Negassa; G C Kabat; T E Rohan; J Crandall
Journal:  Diabetes Obes Metab       Date:  2009-01-21       Impact factor: 6.577

3.  Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload.

Authors:  Robert Brudevold; Torstein Hole; Jens Hammerstrøm
Journal:  PLoS One       Date:  2008-10-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.